Publications

Publications

Filter Results: (1,299) Arrow Down
Filter Results: (1,299) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 34 of 1,299 Results →
  • June 2012
  • Case

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships

By: Arthur A. Daemmrich and Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details
Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Pharmaceutical Industry; Pharmaceutical Industry; Brazil
Related
  • 23 Aug 2016
  • First Look

August 23, 2016

methods. Myth Number 1: Environmental, social, and governance (ESG) programs reduce returns on capital and long-run shareholder value. Reality: Companies committed to ESG are finding competitive advantages in product, labor, and capital... View Details
Keywords: Sean Silverthorne
  • Web

Online Leadership Principles Course | HBS Online

Transform Your Organization Whether you represent a large multinational corporation or a small local business, we have a solution for your learning and development needs. Learn More Our Difference Leadership Principles is designed to help... View Details
  • April 2022
  • Teaching Note

CVS Health: Prescription for Transformation

By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: Health; COVID-19 Pandemic; Primary Care; Leadership; Change Management; Women Executives; Retail; Pharmacy; Pharmacy Benefit Manager; Clinical Trials; Vaccination; Acquisition; Innovation and Invention; Transformation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Related
  • 01 Feb 1999
  • News

Too Much of a Good Thing?

layoffs and lost revenues, for example - weak companies are artificially supported," he explains. "Other firms won't or can't restructure themselves or exit unprofitable businesses because they are too set in their ways, lack sound... View Details
Keywords: Garry Emmons
  • 07 Mar 2017
  • First Look

First Look at New Research, March 7

is a Peruvian grower, exporter, and marketer of fruits and vegetables, with a focus on the high-growth, high-margin blueberry category. Camposol aspires to become Peru’s first multinational branded produce company. It already has a strong... View Details
Keywords: Sean Silverthorne
  • 25 Jan 2017
  • HBS Case

How Should Advertisers Respond to Consumer Demand for Whiter Skin?

Hindustan Unilever, the Indian subsidiary of the multinational company Unilever—and sales skyrocketed, leading other companies to quickly follow with their own products.... View Details
Keywords: by Dina Gerdeman; Beauty & Cosmetics
  • Web

Business Finance Course Online | HBS Online

and potential solutions. Highlights Institutional Investors Signaling Tops Friendly Market Show Hide Details Concepts Capital Market Participants Capital Market Problems Solutions Implications for Your Company Featured Exercises Evaluate... View Details
  • Web

Tsedal Neeley | About

The Language of Global Success: How a Common Tongue Transforms Multinational Organizations chronicles the five-year transformation of a globalizing company. Tsedal's work has been featured in many media outlets, including television and... View Details
  • 22 Aug 2022
  • Research & Ideas

Can Amazon Remake Health Care?

need to do these [things] because we know patients respond to these financial barriers by cutting back on valuable care. Amazon’s not going to fix that problem. Amazon is good at selling other people’s products—but I don’t see it as a View Details
Keywords: by Christina Pazzanese, Harvard Gazette; Health
  • Web

Negotiation Course Online | HBS Online

others. Access Your Free E-Book Upskill Your Team, Transform Your Organization Whether you represent a large multinational corporation or a small local business, we have a solution for your learning and development needs. Learn More Our... View Details
  • Web

Industry Information - Alumni

and user-generated content on companies and career issues. HBS alumni version available via eBaker. Covers information on case interviewing, a description of the industry, and profiles of the top 50 consulting firms. McKinsey Quarterly As... View Details
  • July 2016 (Revised July 2019)
  • Teaching Plan

Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz and Ricardo Andrade
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Related
  • April 2016 (Revised July 2019)
  • Case

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Related
  • 06 Jul 2016
  • What Do You Think?

How Do We Pay for the Costs of Globalization?

magic.’ Sorry, but it hasn’t.” They advanced possible responses with much more reliance on carrots than sticks. David Wittenberg, for example, said that, “Punishing companies for making economically rational decisions violates our... View Details
Keywords: by James L. Heskett; Manufacturing
  • 24 Jul 2018
  • First Look

New Research and Ideas, July 24, 2018

case:https://hbsp.harvard.edu/product/118054-PDF-ENG Harvard Business School Case 318-108 Hikma Pharmaceuticals Governance Journey The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the View Details
Keywords: Dina Gerdeman
  • November 2005
  • Case

Inventec Corporation

By: Krishna G. Palepu and Ingrid Vargas
Inventec Corp., with $4.5 billion in annual revenues, was one of Taiwan's leading original design manufacturers (ODMs). Inventec designed and manufactured electronic products such as computers, servers, MP3 players, PDAs, and cellular telephones for client companies... View Details
Keywords: Multinational Firms and Management; Competitive Strategy; Emerging Markets; Manufacturing Industry; Electronics Industry; China; India
Related
  • 22 Nov 2004
  • Research & Ideas

Side Effects: The Case of Propecia

"staggering" 90 percent brand awareness, she said. The problem: some of that awareness was driven by the much-publicized side effects issue. It was difficult for the drug maker to convey the true risk information necessary to blunt the side effects buzz. The... View Details
Keywords: by Sean Silverthorne; Pharmaceutical; Pharmaceutical
  • Web

Wyss House | About

was rededicated in 2006 to honor Hansjörg Wyss (MBA 1965), chairman and former CEO of Synthes, Inc., a pioneering company in the field of medical technology and devices. In 2004, Wyss established the Hansjörg Wyss Endowment for Doctoral... View Details
  • 28 Jul 2008
  • Research & Ideas

Making the Decision to Franchise (or not)

appears to be true when you get a new type of consumer for the same product." In the pharmaceutical industry, for example, selling medicine to both an independent general practitioner and a hospital will require a different organizational... View Details
Keywords: by Julia Hanna; Retail